Benadryl and Cholangitis sclerosing - a phase IV clinical study of FDA data

Summary:

Cholangitis sclerosing is reported as a side effect among people who take Benadryl (diphenhydramine hydrochloride), especially for people who are female, 30-39 old, have been taking the drug for 2 - 5 years also take Tylenol, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Cholangitis sclerosing when taking Benadryl. It is created by eHealthMe based on reports of 100,139 people who have side effects when taking Benadryl from the FDA, and is updated regularly.

What is Benadryl?

Benadryl has active ingredients of diphenhydramine hydrochloride. It is often used in allergies. eHealthMe is studying from 104,956 Benadryl users. Check the latest studies of Benadryl.

What is Cholangitis sclerosing?

Cholangitis sclerosing (infection and obstruction of bile duct) is found to be associated with 186 drugs and 283 conditions by eHealthMe. Check the latest studies of Cholangitis sclerosing.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

100,139 people reported to have side effects when taking Benadryl.
Among them, 14 people (0.01%) have Cholangitis sclerosing.

Could Benadryl cause Cholangitis sclerosing?

Among these 14 people:

How long have people been on Benadryl when they have Cholangitis sclerosing? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 100 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Cholangitis sclerosing when taking Benadryl? *

  • female: 54.55 %
  • male: 45.45 %

What is the age of people who have Cholangitis sclerosing when taking Benadryl? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 11.11 %
  • 30-39: 33.33 %
  • 40-49: 22.22 %
  • 50-59: 22.22 %
  • 60+: 11.11 %

What are other drugs people take besides Benadryl? *

  1. Tylenol: 6 people, 42.86%
  2. Cyclogyl: 4 people, 28.57%
  3. Durezol: 4 people, 28.57%
  4. Acetaminophen: 3 people, 21.43%
  5. Solu-Cortef: 3 people, 21.43%
  6. Santyl: 2 people, 14.29%
  7. Hydrocortisone: 2 people, 14.29%
  8. Imuran: 2 people, 14.29%
  9. Lisinopril: 2 people, 14.29%
  10. Omeprazole: 2 people, 14.29%

What are other side effects people have besides Cholangitis sclerosing? *

  1. Uveitis (inflammation of the uvea): 4 people, 28.57%
  2. Posterior Capsule Opacification: 4 people, 28.57%
  3. Cataract (clouding of the lens inside the eye): 4 people, 28.57%
  4. Photophobia (extreme sensitivity to light): 4 people, 28.57%
  5. Cholecystitis (infection of gallbladder): 2 people, 14.29%
  6. Epstein-Barr Virus Infection: 2 people, 14.29%
  7. Haemochromatosis (body to absorb more iron than usual from food): 2 people, 14.29%
  8. Histoplasmosis Disseminated (respiratory infection caused by inhaling the spores of the fungus histoplasma capsulatum): 2 people, 14.29%
  9. Jejunal Perforation (a hole in jejunum): 2 people, 14.29%
  10. Abdominal Pain: 2 people, 14.29%

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 35.71%
  2. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 3 people, 21.43%
  3. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 14.29%
  4. Urticaria (rash of round, red welts on the skin that itch intensely): 1 person, 7.14%
  5. Pain: 1 person, 7.14%
  6. Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 1 person, 7.14%
  7. Lung Cancer Metastatic (lung cancer spreads to other parts): 1 person, 7.14%
  8. Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 1 person, 7.14%
  9. High Blood Pressure: 1 person, 7.14%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Benadryl and have Cholangitis sclerosing?

- Check whether Cholangitis sclerosing is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Benadryl:

Cholangitis sclerosing treatments and more:

How severe was Cholangitis sclerosing and when was it recovered:

Expand to all the drugs that have ingredients of diphenhydramine hydrochloride:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Benadryl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cholangitis sclerosing:

Browse all the conditions that are associated with Cholangitis sclerosing:


How the study uses the data?

The study uses data from the FDA. It is based on diphenhydramine hydrochloride (the active ingredients of Benadryl) and Benadryl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: